Press the button and be introduced to a new random company!

Introduce me >

Social media

facebook   Follow us on Twitter

Coverage

Intervacc

Intervacc

Read in Swedish

Intervacc: Strangvac, a vaccine against equine strangles, available for sale in Denmark

15:45 / 31 May 2022 Intervacc Press release

Stockholm, May 31, 2022 - Intervacc announces today that Strangvac, a vaccine against the highly contagious infectious disease equine strangles, has been released for sale in Denmark.

"Strangvac is now available and in stock at our logistics partner in Denmark. It can still take a few days before the vaccine is ready for orders at the local pharmacies. It feels important that we can now offer the vaccine on the Danish market and that we, together with veterinarians and horse owners, can start a new chapter in the fight against equine strangles", says Hege Drangsholt, product specialist and Intervacc's country manager in Denmark.

"We have passed another milestone in the fight against equine strangles when Denmark now becomes the first country outside Sweden where Strangvac is available for sale. We look forward to continuing the launch of Strangvac in Europe", comments Andreas Andersson, Chief Executive Officer of Intervacc.

"It feels great to launch the vaccine in yet another of the Nordic countries. Our product specialist and country manager, Hege Drangsholt has extensive experience in the industry and a great passion for horses. We look forward to meeting veterinarians and horse owners during the WC in Herning in August, as part of our launch plan", says Emma Hartman, global product manager Strangvac.

For more information please contact:

Andreas Andersson, CEO

Phone: +46-8-120 10 601, cell +46-73-335 99 70

E-mail: andreas.andersson@intervacc.com

The information was submitted for publication, through the agency of the contact person set out above on May 31, 2022, 15.45 CET.

About Intervacc

Intervacc AB is a Swedish company within animal health developing safe, effective vaccines for animals. The Company's vaccine candidates are based on several years of research at Karolinska Institutet and Swedish University of Agricultural Research where the foundation was laid for the Company's research and development work. The Intervacc share has been listed on the Nasdaq First North Growth Market since April 2017 with Eminova Fondkommission AB, adviser@eminova.se,+46 (0)8-684 211 10 as Certified Adviser.

About equine strangles

Equine strangles, caused by Streptococcus equi, is the most frequently diagnosed infectious disease of horses, and affects horses all over the world with one exception Iceland where the import of horses is prohibited. Streptococcus equi invades the lymph nodes of head and neck, causing them to swell and form abscesses that can literally strangle, in around 2% of cases, the horse to death. Some of the horses that recover from strangles remain persistently infected. These apparently healthy animals shed bacteria into the environment and spread the disease to other horses with which they come into contact.

Contact information for Certified Adviser

Eminova Fondkommission AB

E-mail: adviser@eminova.se,Phone: +46 (0)8 - 684 211 10

Show as PDF

Show original from Cision

Cision

This information was distributed by Cision http://www.cisionwire.se/